Tech Company Financing Transactions

Vir Biotechnology Funding Round

Private investors participated in a $66 million capital raise for Vir Biotechnology. The round was recorded on 7/2/2018.

Transaction Overview

Company Name
Announced On
7/2/2018
Transaction Type
Venture Equity
Amount
$66,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
499 Illinois 500
San Francisco, CA 94158
USA
Phone
Undisclosed
Email Address
Overview
Vir integrates diverse innovations in science, technology, and medicine to transform the care of people with serious infectious diseases. Vir is taking a multi-program, multi-platform approach to applying these breakthroughs, including the development of treatments that induce protective and therapeutic immune responses.
Profile
Vir Biotechnology LinkedIn Company Profile
Social Media
Vir Biotechnology Company Twitter Account
Company News
Vir Biotechnology News
Facebook
Vir Biotechnology on Facebook
YouTube
Vir Biotechnology on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
George Scangos
  George Scangos LinkedIn Profile  George Scangos Twitter Account  George Scangos News  George Scangos on Facebook
Chief Financial Officer
Howard Horn
  Howard Horn LinkedIn Profile  Howard Horn Twitter Account  Howard Horn News  Howard Horn on Facebook
Chief Information Officer
Alex Bangs
  Alex Bangs LinkedIn Profile  Alex Bangs Twitter Account  Alex Bangs News  Alex Bangs on Facebook
Chief Operating Officer
Alpna Seth
  Alpna Seth LinkedIn Profile  Alpna Seth Twitter Account  Alpna Seth News  Alpna Seth on Facebook
Chief Scientific Officer
Herbert Virgin
  Herbert Virgin LinkedIn Profile  Herbert Virgin Twitter Account  Herbert Virgin News  Herbert Virgin on Facebook
Chief Technical Officer
Michael Kamarck
  Michael Kamarck LinkedIn Profile  Michael Kamarck Twitter Account  Michael Kamarck News  Michael Kamarck on Facebook
Vice President
Philip Pang
  Philip Pang LinkedIn Profile  Philip Pang Twitter Account  Philip Pang News  Philip Pang on Facebook
VP - Bus. Development
Jay Parrish
  Jay Parrish LinkedIn Profile  Jay Parrish Twitter Account  Jay Parrish News  Jay Parrish on Facebook
VP - Human Resources
Eric Schlezinger
  Eric Schlezinger LinkedIn Profile  Eric Schlezinger Twitter Account  Eric Schlezinger News  Eric Schlezinger on Facebook
VP - R & D
Antonio Lanzavecchia
  Antonio Lanzavecchia LinkedIn Profile  Antonio Lanzavecchia Twitter Account  Antonio Lanzavecchia News  Antonio Lanzavecchia on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/2/2018: Project 2020 venture capital transaction
Next: 7/2/2018: Dataminr venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary